<code id='4E7F60353D'></code><style id='4E7F60353D'></style>
    • <acronym id='4E7F60353D'></acronym>
      <center id='4E7F60353D'><center id='4E7F60353D'><tfoot id='4E7F60353D'></tfoot></center><abbr id='4E7F60353D'><dir id='4E7F60353D'><tfoot id='4E7F60353D'></tfoot><noframes id='4E7F60353D'>

    • <optgroup id='4E7F60353D'><strike id='4E7F60353D'><sup id='4E7F60353D'></sup></strike><code id='4E7F60353D'></code></optgroup>
        1. <b id='4E7F60353D'><label id='4E7F60353D'><select id='4E7F60353D'><dt id='4E7F60353D'><span id='4E7F60353D'></span></dt></select></label></b><u id='4E7F60353D'></u>
          <i id='4E7F60353D'><strike id='4E7F60353D'><tt id='4E7F60353D'><pre id='4E7F60353D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:84918
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          What don’t we know about an Alzheimer’s drug side effect?

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSincetheFDA’sapprovaloflecanemab(marketedasLeqembi)andMe